AAAAAA

   
Results: 1-7 |
Results: 7
CONCOMITANT CISPLATIN 5-FU INFUSION AND RADIOTHERAPY IN ADVANCED HEADAND NECK-CANCER - 8-YEAR ANALYSIS OF RESULTS/
Authors: TAYLOR SG MURTHY AK GRIEM KL RECINE DC KIEL K BLENDOWSKI C HURST PB SHOWEL JT HUTCHINSON JC CAMPANELLA RS CHEN SD CALDARELLI DD
Citation: Sg. Taylor et al., CONCOMITANT CISPLATIN 5-FU INFUSION AND RADIOTHERAPY IN ADVANCED HEADAND NECK-CANCER - 8-YEAR ANALYSIS OF RESULTS/, Head & neck, 19(8), 1997, pp. 684-691
A PHASE-II TRIAL OF COMBINED-MODALITY THERAPY IN STAGE IIIB BREAST-CANCER - IS BREAST-CONSERVING THERAPY (BCT) AN OPTION
Authors: BAKER KF COBLEIGH MA WITT TR GRIEM KL
Citation: Kf. Baker et al., A PHASE-II TRIAL OF COMBINED-MODALITY THERAPY IN STAGE IIIB BREAST-CANCER - IS BREAST-CONSERVING THERAPY (BCT) AN OPTION, Radiology, 205, 1997, pp. 335-335
OMISSION OF AXILLARY LYMPH-NODE DISSECTION IN EARLY-STAGE BREAST-CANCER - EFFECT ON TREATMENT OUTCOME
Authors: KUZNETSOVA M GRAYBILL JC ZUSAG TW HARTSELL WF GRIEM KL
Citation: M. Kuznetsova et al., OMISSION OF AXILLARY LYMPH-NODE DISSECTION IN EARLY-STAGE BREAST-CANCER - EFFECT ON TREATMENT OUTCOME, Radiology, 197(2), 1995, pp. 507-510
DELAYING THE INITIATION OF INTACT BREAST IRRADIATION FOR PATIENTS WITH LYMPH-NODE POSITIVE BREAST-CANCER INCREASES THE RISK OF LOCAL RECURRENCE
Authors: HARTSELL WF RECINE DC GRIEM KL MURTHY AK
Citation: Wf. Hartsell et al., DELAYING THE INITIATION OF INTACT BREAST IRRADIATION FOR PATIENTS WITH LYMPH-NODE POSITIVE BREAST-CANCER INCREASES THE RISK OF LOCAL RECURRENCE, Cancer, 76(12), 1995, pp. 2497-2503
RANDOMIZED COMPARISON OF NEOADJUVANT CISPLATIN AND FLUOROURACIL INFUSION FOLLOWED BY RADIATION VERSUS CONCOMITANT TREATMENT IN ADVANCED HEAD AND NECK-CANCER
Authors: TAYLOR SG MURTHY AK VANNETZEL JM COLIN P DRAY M CALDARELLI DD SHOTT S VOKES E SHOWEL JL HUTCHINSON JC WITT TR GRIEM KL HARTSELL WF KIES MS MITTAL B REBISCHUNG JL COUPEZ DJ DESPHIEUX JL BOBIN S LEPAJOLEC C
Citation: Sg. Taylor et al., RANDOMIZED COMPARISON OF NEOADJUVANT CISPLATIN AND FLUOROURACIL INFUSION FOLLOWED BY RADIATION VERSUS CONCOMITANT TREATMENT IN ADVANCED HEAD AND NECK-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 385-395
PRIMARY RADIATION-THERAPY TO T1 AND T2 BREAST-CANCER FOLLOWING CONSERVATIVE SURGERY - WHICH PATIENTS SHOULD BE BOOSTED
Authors: GALINSKY DL SHARMA M HARTSELL WF GRIEM KL MURTHY A
Citation: Dl. Galinsky et al., PRIMARY RADIATION-THERAPY TO T1 AND T2 BREAST-CANCER FOLLOWING CONSERVATIVE SURGERY - WHICH PATIENTS SHOULD BE BOOSTED, American journal of clinical oncology, 17(1), 1994, pp. 60-63
WHAT IS THE SIGNIFICANCE OF A LOBULAR CARCINOMA IN-SITU (LCIS) COMPONENT IN WOMEN TREATED WITH BREAST-CONSERVING THERAPY (BCT) FOR EARLY-STAGE BREAST-CANCER
Authors: GRIEM KL HARTSELL WF RECINE DC STJULIEN M WITT TR BINES S STAREN E MURTHY AK
Citation: Kl. Griem et al., WHAT IS THE SIGNIFICANCE OF A LOBULAR CARCINOMA IN-SITU (LCIS) COMPONENT IN WOMEN TREATED WITH BREAST-CONSERVING THERAPY (BCT) FOR EARLY-STAGE BREAST-CANCER, International journal of radiation oncology, biology, physics, 27, 1993, pp. 269-269
Risultati: 1-7 |